Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2 Thoracic 1 Other hematologic neoplasm 1 Head & Neck 1

Conditions

Head and Neck Neoplasms 20 Squamous Cell Carcinoma of Head and Neck 11 Mouth Neoplasms 6 Lung Neoplasms 5 Head and Neck Carcinoma 5 Oropharyngeal Neoplasms 4 Laryngeal Neoplasms 4 Stomatitis 3 Xerostomia 2 Hypopharyngeal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Ulcer 1 Tonsillar Neoplasms 1 Tongue Neoplasms 1 Tobacco Use 1 Speech 1 Recurrence 1 Parotid Neoplasms 1 Parathyroid Neoplasms 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Mucositis 1 Maxillary Sinus Neoplasms 1 Lymphedema 1 Localized Head and Neck Carcinoma 1 Hyperparathyroidism, Primary 1 Hypercalcemia 1 Fibrosis 1 Esophageal Neoplasms 1

Interventions

Therapeutics 2 Virtual Reality Exposure Therapy 1 Transurethral Resection of Prostate 1 Thyroxine 1 Thyroidectomy 1 Surveys and Questionnaires 1 Standard of Care 1 Self Care 1 Psychiatric Rehabilitation 1 Lysine Acetyltransferase 5 1 Imagery, Psychotherapy 1 Hypnosis 1 Holistic Health 1 Educational Status 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Anxiety Disorders × Standard of Care × Head & Neck × Clear all

NCT04671485 2025-07-24

HYMACO

Institut de Cancérologie de Lorraine

Phase NA Completed

Anxiety Disorders, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡